Similarly, our study demonstrated that the combination of sea cucumber polysaccharides (SCPs) with anti-PD-1 therapy significantly reduced the tumor size in a colon cancer mouse model compared to the effects of anti-PD-1 treatment alone, suggesting a synergistic effect between SCPs and ICIs in enhancing anti-tumor immunity. Here, PDCD1 is linked to malignant colon neoplasm.